Status:
RECRUITING
Dexmedetomidine Versus Lidocaine Infusions as Adjuvants to General Anesthesia for Chronic Pain Management After Mastectomy
Lead Sponsor:
Cairo University
Conditions:
Dexmedetomidine
Lidocaine
Eligibility:
FEMALE
18-75 years
Phase:
NA
Brief Summary
This study aims to compare dexmedetomidine and lidocaine infusions as adjuvants to general anesthesia for chronic pain management after mastectomy.
Detailed Description
Chronic pain after breast cancer surgery is a significant problem that is expected to become more relevant because the number of patients undergoing breast cancer surgery is increasing owing to the lo...
Eligibility Criteria
Inclusion
- Age from 18 to 75 years.
- American Society of Anesthesiologists (ASA) physical status II.
- Scheduled for mastectomy with axillary dissection (either modified radical mastectomy with or without latissimus dorsi flap or conservative breast surgery) due to breast cancer.
Exclusion
- Patient refusal.
- Known allergy to any of the study drugs.
- Those with hepatic or renal insufficiency.
- Patients who are running regularly on B blockers.
- α2 adrenergic agonists and sedatives.
- Psychoactive medications.
Key Trial Info
Start Date :
April 5 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06910644
Start Date
April 5 2025
End Date
December 1 2025
Last Update
April 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University
Cairo, Egypt, 12613